Extraintestinal manifestations of inflammatory bowel disease.

被引：0
作者：
Bernstein C.N. [1 ]
机构：
[1] University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, John Buhler Research Centre, MD804F-715 McDermot Avenue, Winnipeg, R3E-3P4, Manitoba
来源：
Current Gastroenterology Reports | 2001年 / 3卷 / 6期
基金：
加拿大健康研究院;
关键词：
Bone Mineral Density; Inflammatory Bowel Disease; Ulcerative Colitis; Fracture Risk; Primary Sclerosing Cholangitis;
D O I：
10.1007/s11894-001-0068-6
中图分类号：
学科分类号：
摘要：
Patients with inflammatory bowel disease (IBD) may confront a variety of nonintestinal problems. The first North American population-based data describing the incidence rates of several of these disorders have been reported over the past year. Reports have also documented our expanding knowledge of peristomal pyoderma gangrenosum, and of ulcerative colitis following liver transplantation in patients with primary sclerosing cholangitis. Osteopenia continues to receive considerable attention. Factors such as osteoprotegrin ligand, and its interaction with receptor activator of nuclear factor kappa B, are connected with T-cell activity, inflammation, and osteoclastogenesis. Studies in these and other areas are addressed in this review.
引用
收藏
页码：477 / 483
页数：6
相关论文
共 87 条
[1]  
Bernstein CN(2001)The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study Am J Gastroenterol 96 1116-1122
[2]  
Blanchard JF(1999)The epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian province: a population-based study Am J Epidemiol 149 916-924
[3]  
Rawsthorne P(2001)Cutaneous manifestations in inflammatory bowel disease Z Gastroenterol 39 137-144
[4]  
Yu N(2001)Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease Inflamm Bowel Dis 7 1-7
[5]  
Bernstein CN(2000)Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management Arch Surg 135 564-568
[6]  
Blanchard JF(2000)Clinical features and treatment of peristomal pyoderma gangrenosum JAMA 284 1546-1548
[7]  
Rawsthorne P(1997)Sclerosing cholangitis, race and sex Gut 41 688-689
[8]  
Wajda A(1998)Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins Hepatology 28 332-340
[9]  
Tromm A(2000)‘Atypical p-ANCA‘ in IBD and hepatobiliary disorders reacts with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines Gastroenterology 119 310-322
[10]  
May D(1998)Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case control study Hepatology 27 311-316
123456789